BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Pictilisib

2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine [Supplementary Concept] has antineoplastic activity; structure in first source Heading Mapped to: Indazoles Sulfonamides

25+ PubMed studies analyzed · 3 RCTs · Evidence Score: 43.2

Research Domains

Pictilisib has been studied across 6 research domains including 🔬 Oncology, 🧬 Hormones, ⏳ Longevity & Aging, 🧠 Focus & Attention, 🏋️ Muscle & Hypertrophy. The primary research focus is 🔬 Oncology with 76% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Pictilisib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

pi
24 shared targets
ly294002
20 shared targets
scriptaid
17 shared targets
Afatinib
22 shared targets
fimepinostat
16 shared targets
tg100
24 shared targets
torin
16 shared targets
quisinostat
14 shared targets
midostaurin
38 shared targets
alpelisib
13 shared targets
Loading evidence profile...

This evidence profile for Pictilisib is generated deterministically from 25 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.